Tricuspid repair firm 4Tech taps ex-Boston Scientific execs for CEO, CMO | Personnel Moves for Feb. 27, 2018

4Tech said last week that it named a pair of Boston Scientific (NYSE:BSX) veterans as its new CEO and CMO, with onetime chief Mike Ennen stepping away for “family reasons.”

Galway, Ireland-based 4Tech said former Boston transcatheter aortic valve GM Tom Fleming is slated to take the reins from Thoratec vet Ennen as president & CEO in March. The company, which is developing the TriClinch Coil transcatheter tricuspid valve repair device, also said that Dr. Keith Dawkins, Boston’s ex-global medical chief, was named CMO effective Feb. 22.

Z-Medica lures ex-Hologic COO Compton
Z-Medica said it named former Hologic (NSDQ:HOLX) COO Eric Compton to be its new president & CEO, replacing Stephen Fanning, who is stepping down “to pursue a new career opportunity that will allow him to be closer to his family and home on the West Coast,” the hemostat company said.
Read more

Check-Cap promotes COO Ovadia to CEO
Check-Cap (NSDQ:CHEK) promoted Alex Ovadia from COO and R&D VP to CEO, succeeding Bill Densel, “who will provide support to complete a seamless transition,” the company said.
Read more

Invacare makes it official with interim CFO Leneghan
Invacare (NYSE:IVC) made it official with interim CFO Kathleen Leneghan, naming her SVP and finance chief effective Feb. 22. Leneghan took over last November, when former CFO Robert Gudbranson announced his retirement.
Read more

Imagion Biosystems names Bischoff as clinical VP
Imagion Biosystems (ASX:IBX) said it named Farideh Bischoff as VP of clinical research.
Read more

Limflow looks to Claret Medical, Medtronic vets for R&D, sales VPs
LimFlow said it appointed former Claret Medical QA & regulatory affairs VP Zachary Woodson as its own regulatory affairs VP and tapped medtech veteran Theo Mastrokostopoulos as sales & market development VP. The company also named ex-Mölnlycke Health CareCEO Pierre Guyot as chairman of the board.
Read more